Dapirolizumab pegolCDP7657BI655064CFZ533Iscalimabsystemic lupus erythematosuslupus nephritisSLE
…i: 10.3390/cells13191621Clowse M, Isenberg D, Merrill J, et al. Dapirolizumab pegol demonstrated significant improvement in systemic lupus erythema…
4articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: dapirolizumab pegol ×
dapirolizumab pegol
This drug is selected. Its supporting articles are shown below.
Articles mentioning dapirolizumab pegol
4 articles · page 1 of 1Dapirolizumab pegolDZPprednisoneSLESLE-specificLupus
… including fatigue, musculoskeletal pain and morning stiffness. Dapirolizumab pegol (DZP) is a novel CD40L inhibitor with broad modulatory effects …
dapirolizumab pegolDZPprednisonePBOSLELupusNCT04294667
… outcomes, from the phase 3 PHOENYCS GO trial ( NCT04294667) of dapirolizumab pegol (DZP).DZP is a novel CD40L inhibitor with broad modulatory effe…
dapirolizumab pegolDZPprednisonePBOBILAG-2004
…using data from the phase 3 PHOENYCS GO trial ( NCT04294667) of dapirolizumab pegol (DZP).DZP, a novel CD40L inhibitor, consists of a polyethylene …